The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

Cinedigm Shares Soar 170% Higher on Global Distribution Deal
Source: Streetwise Reports (06/04/2020)

Shares of Cinedigm Corp. reached a new 52-week high after the company reported that it is partnering with the world's largest smart TV solutions provider, Vewd, for global over-the-top channel distribution.

Cassava Shares Rise on Updated Phase 2b Alzheimer's Drug Trial Data
Source: Streetwise Reports (06/03/2020)

Shares of Cassava Sciences traded 70% higher after the firm provided updates from its Phase 2b study of PTI-125 for use in treating Alzheimer' disease.

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19
Source: Streetwise Reports (06/03/2020)

Revive Therapeutics is focused on infectious diseases as well as treatments using psilocybin-based formulations.

Shares of Westwater Resources traded higher on greater than 100-times average daily volume after the company reported that positive independent test results on ULTRA-PMG™ demonstrated successful simulated full-scale processing of battery graphite.

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug
Source: Streetwise Reports (06/01/2020)

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids.

Zscaler Shares Trade Up 25% After Landing US DIU Secure Cloud Contract
Source: Streetwise Reports (05/29/2020)

Shares of Zscaler Inc. set a new 52-week high price after the company reported that it was selected by the U.S. DoD's Defense Innovation Unit for a secure cloud management project.

Dollar Tree Shares Climb 11% after Posting 8.2% Sales Growth in Q1/20
Source: Streetwise Reports (05/28/2020)

Dollar Tree shares traded higher after the firm reported Q1/20 financial results that included an 8.2% y-o-y increase in consolidated net sales fueled by a 15% y-o-y increase in same-store sales at its Family Dollar locations.

Mersana Therapeutics Trades 60% Higher on Positive Phase 1 Ovarian Cancer Trial Data
Source: Streetwise Reports (05/27/2020)

Shares of Mersana Therapeutics reached a new 52-week high price after the company reported positive interim data from the expanded portion of its Phase 1 study of XMT-1536 for treatment of ovarian cancer.